Clinical Trial Update: Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC) [Phase 2]

View source ↗

Summary

Phase 2a trial update for PL-8177 in subjects with active Ulcerative Colitis; the study is currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• PL-8177 (PL-8177)

Snippet

Sponsor: Palatin Technologies, Inc | Conditions: Ulcerative Colitis, Ulcerative Colitis Acute | Phase 2 | Status: ACTIVE_NOT_RECRUITING